52.27
-0.12
(-0.23%)
At close: 3:30:02 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
17,604,978
16,821,343
14,139,548
15,415,651
11,753,673
Cost of Revenue
11,211,769
10,835,229
9,703,728
10,609,373
7,867,766
Gross Profit
6,393,209
5,986,114
4,435,820
4,806,278
3,885,907
Operating Expense
4,812,504
4,734,563
3,919,795
3,715,980
3,003,598
Operating Income
1,580,705
1,251,551
516,025
1,090,298
882,309
Net Non Operating Interest Income Expense
-19,652
-12,061
-3,234
-10,963
3,461
Pretax Income
1,715,965
1,354,157
557,553
1,267,026
985,115
Tax Provision
451,505
387,954
170,798
250,213
14,215
Net Income Common Stockholders
1,259,856
961,599
386,752
1,016,827
970,859
Diluted NI Available to Com Stockholders
1,259,856
961,599
386,752
1,016,827
970,859
Basic EPS
2.40
1.88
0.77
2.26
2.16
Diluted EPS
2.40
1.88
0.77
1.96
2.15
Basic Average Shares
524,492.05
511,168.71
502,206.57
449,979.63
449,826.20
Diluted Average Shares
524,492.05
511,168.71
502,206.57
519,826.20
451,072.78
Rent Expense Supplemental
--
120,812
107,401
81,823
51,400
Total Expenses
16,024,273
15,569,792
13,623,523
14,325,353
10,871,364
Net Income from Continuing & Discontinued Operation
1,259,856
961,599
386,752
1,016,827
970,859
Normalized Income
1,259,856
961,599
386,752
1,016,827
970,859
Interest Income
--
25,041
16,574
13,298
21,343
Interest Expense
44,693
37,102
19,808
24,261
12,990
Net Interest Income
-19,652
-12,061
-3,234
-10,963
3,461
EBIT
1,760,658
1,391,259
577,361
1,291,287
998,105
EBITDA
1,982,031
1,725,954
856,665
1,567,712
1,300,938
Reconciled Cost of Revenue
11,211,769
10,835,229
9,703,728
10,609,373
7,867,766
Reconciled Depreciation
221,373
334,695
279,304
276,425
302,833
Net Income from Continuing Operation Net Minority Interest
1,259,856
961,599
386,752
1,016,827
970,859
Normalized EBITDA
1,982,031
1,725,954
856,665
1,567,712
1,300,938
Tax Rate for Calcs
0
0
0
0
0
3/31/2021 - 1/1/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SIGACHI.NS Sigachi Industries Limited
39.45
-1.10%
NECLIFE.BO Nectar Lifesciences Limited
22.89
+0.48%
SYNCOMF.NS Syncom Formulations (India) Limited
17.39
-0.06%
SPARC.NS Sun Pharma Advanced Research Company Limited
150.36
+1.61%
AKUMS.NS AKUMS DRUGS AND PHARMA L
499.15
+4.61%
ABBOTINDIA.NS Abbott India Limited
30,710.00
-0.78%
PPLPHARMA.NS Piramal Pharma Limited
221.84
-0.31%
BALPHARMA.NS Bal Pharma Limited
106.41
+0.44%
AARTIDRUGS.BO Aarti Drugs Limited
358.25
+0.69%
LASA.BO Lasa Supergenerics Limited
17.62
-0.51%